Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
about
Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysisPersonalized treatment strategies in glioblastoma: MGMT promoter methylation status.Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality.Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Temozolomide in the Era of Precision Medicine.Antagonism of NF-κB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD)-anti-NF-κB vs. anti-miRNA strategies.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis.BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas.Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma
P2860
Q34076281-43436128-BB75-47CD-A5CC-B4AF2FE80012Q35078800-F62B3F34-AB92-465F-B514-70F85370C1EEQ36268061-17D6AA45-5629-40E8-8730-63CFD4D5DB53Q37221207-987B5A8D-CF88-4867-B656-1472795D51BBQ37290850-753CFDEE-0996-42A6-ADAF-7C685E746D8BQ37536543-AA09B6F7-48BC-46C9-A0BD-2E326FDD4798Q37674285-0A3D60B3-5DA7-48A0-9F1A-78EA252D70EDQ38187997-CC2E886A-4920-4F5B-A5BA-FE8665F486F4Q38718010-ED55D7EA-242D-486A-87F2-E895DD399BE5Q40247856-ED3B7B48-F111-4EA3-AD91-419E021EBE28Q47942947-960E1F90-C608-42AC-A065-C6C809E593E6Q48311392-714BE85F-AD81-4D1D-8BDF-448F6BE5B4DAQ49640790-02312D91-1392-46C8-9780-2560D3C6770AQ57180130-C204B499-67C7-42AA-9C89-5233AC3C8A4A
P2860
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@ast
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@en
type
label
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@ast
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@en
prefLabel
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@ast
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@en
P2093
P2860
P356
P1476
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.
@en
P2093
Lawrence Recht
Reena P Thomas
Seema Nagpal
P2860
P356
10.2147/CPAA.S26586
P407
P577
2012-12-27T00:00:00Z